Rheumatoid arthritis and cardiovascular disease

American Heart Journal

Volumn 166, Issue 4, 2013, Pages

  Crowson, Cynthia S ^a   Liao, Katherine P ^b   Davis III, John M ^a   Solomon, Daniel H ^b   Matteson, Eric L ^a   Knutson, Keith L ^a   Hlatky, Mark A ^c   Gabriel, Sherine E ^a  

^a MAYO CLINIC   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; ATORVASTATIN; C REACTIVE PROTEIN; CD28 ANTIGEN; CD34 ANTIGEN; CELECOXIB; CHOLESTEROL; CYCLOOXYGENASE 2 INHIBITOR; GAMMA INTERFERON; GLUCOCORTICOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HLA DRB1 ANTIGEN; HYDROXYCHLOROQUINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUPROFEN; INTERLEUKIN 17; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHOTREXATE; NAPROXEN; PREDNISONE; PROTEIN ANTIBODY; RHEUMATOID FACTOR; RITUXIMAB; ROFECOXIB; SERUM AMYLOID A; TOCILIZUMAB; TUMOR NECROSIS FACTOR INHIBITOR;

AEROBIC EXERCISE; ANGINA PECTORIS; ARTERIAL STIFFNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY MASS; CACHEXIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CD4+ T LYMPHOCYTE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; GASTROINTESTINAL HEMORRHAGE; GENE; GENETIC PREDISPOSITION; HEART DISEASE; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART INFARCTION PREVENTION; HEMATOPOIETIC STEM CELL; HLA DRB1 ANTIGEN GENE; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; LOW DRUG DOSE; MUSCLE MASS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANCE TRAINING; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SIDE EFFECT; SMOKING CESSATION; TELOMERE SHORTENING; THORAX PAIN;

EID: 84885172666     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.07.010     Document Type: Review

References (79)

1. D.H. Solomon, N.J. Goodson, and J.N. Katz Patterns of cardiovascular risk in rheumatoid arthritis Ann Rheum Dis 65 2006 1608 1612
2. H. Maradit-Kremers, C.S. Crowson, and P.J. Nicola Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study Arthritis Rheum 52 2005 402 411
3. M.J. Peters, V.P. van Halm, and A.E. Voskuyl Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study Arthritis Rheum 61 2009 1571 1579
4. M.J. Peters, D.P. Symmons, and D. McCarey EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis Ann Rheum Dis 69 2010 325 331
5. P.J. Nicola, H. Maradit-Kremers, and V.L. Roger The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years Arthritis Rheum 52 2005 412 420
6. J.M. Davis 3rd, V.L. Roger, and C.S. Crowson The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population Arthritis Rheum 58 2008 2603 2611
7. M.L. Francis, J.J. Varghese, and J.M. Mathew Outcomes in patients with rheumatoid arthritis and myocardial infarction Am J Med 123 2010 922 928
8. B. Zoller, X. Li, and J. Sundquist Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden BMC Neurol 12 2012 41
9. A.K. Bacani, S.E. Gabriel, and C.S. Crowson Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum 64 2012 53 61
10. K.P. Liang, K.V. Liang, and E.L. Matteson Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations Arthritis Rheum 54 2006 642 648
11. K.S. Stamatelopoulos, G.D. Kitas, and C.M. Papamichael Subclinical peripheral arterial disease in rheumatoid arthritis Atherosclerosis 212 2010 305 309
12. J.K. Alkaabi, M. Ho, and R. Levison Rheumatoid arthritis and macrovascular disease Rheumatology 42 2003 292 297
13. M.E. Holmqvist, M. Neovius, and J. Eriksson Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization JAMA 308 2012 1350 1356
14. E. Myasoedova, C.S. Crowson, and H. Maradit Kremers Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease Ann Rheum Dis 69 2010 495
15. T.E. Toms, D.P. Symmons, and G.D. Kitas Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors Curr Vasc Pharmacol 8 2010 301 326
16. J. Watanabe, C. Charles-Schoeman, and Y. Miao Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis Arthritis Rheum 64 2012 1828 1837
17. H.M. Maradit Kremers, P.J. Nicola, and C.S. Crowson Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis Arthritis Rheum 50 2004 3450 3457
18. J.T. Giles, M. Allison, and R.S. Blumenthal Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics Arthritis Rheum 62 2010 3173 3182
19. V.F. Panoulas, K.M. Douglas, and H.J. Milionis Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis Rheumatology (Oxford) 46 2007 1477 1482
20. H. Maradit-Kremers, P.J. Nicola, and C.S. Crowson Cardiovascular death in rheumatoid arthritis: a population-based study Arthritis Rheum 52 2005 722 732
21. K.P. Liang, H.M. Kremers, and C.S. Crowson Autoantibodies and the risk of cardiovascular events J Rheumatol 36 2009 2462 2469
22. T. Sokka, and A. Hakkinen Poor physical fitness and performance as predictors of mortality in normal populations and patients with rheumatic and other diseases Clin Exp Rheumatol 26 2008 S14 S20
23. C.J. Lavie, R.J. Thomas, and R.W. Squires Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary heart disease Mayo Clin Proc 84 2009 373 383
24. J.K. Cooney, R.J. Law, and V. Matschke Benefits of exercise in rheumatoid arthritis J Aging Res 2011 2011 681640
25. A.B. Lemmey, S.M. Marcora, and K. Chester Effects of high-intensity resistance training in patients with rheumatoid arthritis: a randomized controlled trial Arthritis Rheum 61 2009 1726 1734
26. Z. de Jong, M. Munneke, and A.H. Zwinderman Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trial Arthritis Rheum 48 2003 2415 2424
27. C.H. van den Ende, F.C. Breedveld, and S. le Cessie Effect of intensive exercise on patients with active rheumatoid arthritis: a randomised clinical trial Ann Rheum Dis 59 2000 615 621
28. G.B. Neuberger, L.S. Aaronson, and B. Gajewski Predictors of exercise and effects of exercise on symptoms, function, aerobic fitness, and disease outcomes of rheumatoid arthritis Arthritis Rheum 57 2007 943 952
29. L. Noreau, H. Martineau, and L. Roy Effects of a modified dance-based exercise on cardiorespiratory fitness, psychological state and health status of persons with rheumatoid arthritis Am J Phys Med Rehabil 74 1995 19 27
30. H.M. Maradit Kremers, M. Bidaut-Russell, and C.G. Scott Preventive medical services among patients with rheumatoid arthritis J Rheumatol 30 2003 1940 1947
31. S.S. Desai, J.D. Myles, and M.J. Kaplan Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis Arthritis Res Ther 14 2012 R270
32. S. Van Doornum, C. Brand, and V. Sundararajan Rheumatoid arthritis patients receive less frequent acute reperfusion and secondary prevention therapy after myocardial infarction compared with the general population Arthritis Res Ther 12 2010 R183
33. P.H. Dessein, B.I. Joffe, and A.E. Stanwix Glucocorticoids and insulin sensitivity in rheumatoid arthritis J Rheumatol 31 2004 867 874
34. I. Hafstrom, M. Rohani, and S. Deneberg Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis-a randomized study J Rheumatol 34 2007 1810 1816
35. J.M. Davis 3rd, H. Maradit Kremers, and C.S. Crowson Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study Arthritis Rheum 56 2007 820 830
36. C. Bombardier, L. Laine, and A. Reicin Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group N Engl J Med 343 2000 1520 1528
37. F.E. Silverstein, G. Faich, and J.L. Goldstein Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study JAMA 284 2000 1247 1255
38. S. Trelle, S. Reichenbach, and S. Wandel Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis BMJ 342 2011 c7086
39. M.C. Becker, T.H. Wang, and L. Wisniewski Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis Am Heart J 157 2009 606 612
40. R. Micha, F. Imamura, and M. Wyler von Ballmoos Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease Am J Cardiol 108 2011 1362 1370
41. A.N. Georgiadis, E.C. Papavasiliou, and E.S. Lourida Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment - a prospective, controlled study Arthritis Res Ther 8 2006 R82
42. P.M. Ridker Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT) J Thromb Haemost 7 Suppl. 1 2009 332 339
43. C. Barnabe, B.J. Martin, and W.A. Ghali Systematic review and meta-analysis: anti-tumor necrosis factor alpha therapy and cardiovascular events in rheumatoid arthritis Arthritis Care Res (Hoboken) 63 2011 522 529
44. L.S. Tam, B. Tomlinson, and T.T. Chu Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis Clin Rheumatol 26 2007 1495 1498
45. A. Jamnitski, I.M. Visman, and M.J. Peters Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study Ann Rheum Dis 69 2010 1929 1933
46. D. Hurlimann, A. Forster, and G. Noll Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis Circulation 106 2002 2184 2187
47. K. Angel, S.A. Provan, and H.L. Gulseth Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study Hypertension 55 2010 333 338
48. S. Van Doornum, G. McColl, and I.P. Wicks Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis Rheumatology (Oxford) 44 2005 1428 1432
49. M.C. Wasko, H.B. Hubert, and V.B. Lingala Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis JAMA 298 2007 187 193
50. S.J. Morris, M.C. Wasko, and J.L. Antohe Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients Arthritis Care Res (Hoboken) 63 2011 530 534
51. J.A. Singh, S. Beg, and M.A. Lopez-Olivo Tocilizumab for rheumatoid arthritis: a Cochrane systematic review J Rheumatol 38 2011 10 20
52. D.W. McCarey, I.B. McInnes, and R. Madhok Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial Lancet 363 2004 2015 2021
53. S. Van Doornum, G. McColl, and I.P. Wicks Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis Ann Rheum Dis 63 2004 1571 1575
54. F. Hermann, A. Forster, and R. Chenevard Simvastatin improves endothelial function in patients with rheumatoid arthritis J Am Coll Cardiol 45 2005 461 464
55. M.A. De Vera, H. Choi, and M. Abrahamowicz Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study Ann Rheum Dis 70 2011 1020 1024
56. E.E. Arts, T.L. Jansen, and A. Den Broeder Statins inhibit the antirheumatic effects of rituximab in rheumatoid arthritis: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry Ann Rheum Dis 70 2011 877 878
57. J.F. Fries, D.R. Ramey, and G. Singh A reevaluation of aspirin therapy in rheumatoid arthritis Arch Intern Med 153 1993 2465 2471
58. C. Weber, and H. Noels Atherosclerosis: current pathogenesis and therapeutic options Nat Med 17 2011 1410 1422
59. I.B. McInnes, and G. Schett The pathogenesis of rheumatoid arthritis N Engl J Med 365 2011 2205 2219
60. R. Paakkanen, M.L. Lokki, and M. Seppanen Proinflammatory HLA-DRB1*01-haplotype predisposes to ST-elevation myocardial infarction Atherosclerosis 221 2012 461 466
61. W. Sun, Y. Cui, and L. Zhen Association between HLA-DRB1, HLA-DRQB1 alleles, and CD4(+)CD28(null) T cells in a Chinese population with coronary heart disease Mol Biol Rep 38 2011 1675 1679
62. R.E. Eid, D.A. Rao, and J. Zhou Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells Circulation 119 2009 1424 1432
63. K. Nistala, S. Adams, and H. Cambrook Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment Proc Natl Acad Sci USA 107 2010 14751 14756
64. J.M. Kremer, H.K. Genant, and L.W. Moreland Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial Ann Intern Med 144 2006 865 876
65. A. Schomig, A. Dibra, and S. Windecker A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease J Am Coll Cardiol 50 2007 1373 1380
66. A.N. Vallejo CD28 extinction in human T cells: altered functions and the program of T-cell senescence Immunol Rev 205 2005 158 169
67. - T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients Circulation 109 2004 2744 2748
68. + T cells in severe rheumatoid arthritis Arthritis Rheum 40 1997 1106 1114
69. T. Nakajima, S. Schulte, and K.J. Warrington T-cell-mediated lysis of endothelial cells in acute coronary syndromes Circulation 105 2002 570 575
70. S.O. Schonland, C. Lopez, and T. Widmann Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages Proc Natl Acad Sci USA 100 2003 13471 13476
71. I. Colmegna, A. Diaz-Borjon, and H. Fujii Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis Arthritis Rheum 58 2008 990 1000
72. L. Shao, H. Fujii, and I. Colmegna Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis J Exp Med 206 2009 1435 1449
73. H. Fujii, L. Shao, and I. Colmegna Telomerase insufficiency in rheumatoid arthritis Proc Natl Acad Sci USA 106 2009 4360 4365
74. I. Spyridopoulos, J. Hoffmann, and A. Aicher Accelerated telomere shortening in leukocyte subpopulations of patients with coronary heart disease: role of cytomegalovirus seropositivity Circulation 120 2009 1364 1372
75. C.M. Weyand, H. Fujii, and L. Shao Rejuvenating the immune system in rheumatoid arthritis Nat Rev Rheumatol 5 2009 583 588
76. P.M. Ridker Moving beyond JUPITER: will inhibiting inflammation reduce vascular event rates? Curr Atheroscler Rep 15 2013 295
77. M.C. Genovese, J.C. Becker, and M. Schiff Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition N Engl J Med 353 2005 1114 1123
78. J.S. Smolen, A. Beaulieu, and A. Rubbert-Roth Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial Lancet 371 2008 987 997
79. P.M. Ridker, T. Thuren, and A. Zalewski Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) Am Heart J 162 2011 597 605